Google Cloud and Babylon Health collaborate to improve patient care
Collaboration between Babylon Health and tech giant seeks to speed up historically slow patient access to data
Read More
Tag: Google
Boehringer Ingelheim announces partnership with Google
Partnership will aim to research and implement quantum computing in pharma R&D
Read More
Sanofi, Google link up for new healthcare innovation lab
The collaboration will leverage deep analytics across data sets to better understand key diseases.
Read More
UK startup developing flu jab attracts £20m investment
A UK startup spun out from Oxford University in 2016 currently working on a universal flu vaccine is being backed by Google parent company Alphabet.
Read More
NHS trust breached data law in DeepMind deal
The UK’s Information Commissioner’s Office says the Royal Free NHS Foundation Trust breached the Data Protection Act when it handed over patient data to Google’s artificial intelligence arm DeepMind.
Read More
Research paper slams DeepMind/Royal Free NHS Trusts data deal
A controversial deal between Google’s artificial intelligence unit DeepMind and The Royal Free London NHS Foundation Trust has come under fire for “inexcusable” failings and a lack of transparency in an academic paper published in Health and Technology.
Read More
Sanofi teams up with Verily to create diabetes JV
French drugmaker Sanofi has teamed up with Alphabet’s US-based life sciences company Verily (formerly Google Life Sciences) to launch of a joint-venture – Onduo – with the aim of improving the management of diabetes.
Read More
Google DeepMind, UCLH link for AI-based cancer treatment
Google’s artificial intelligence unit DeepMind and University College London Hospitals Foundation Trust have linked in under a medical research partnership aiming to develop pioneering technology able to automatically differentiate between cancerous and healthy tissues on patient scans.
Read More
GSK teams up with Google on bioelectronic medicines
GlaxoSmithKline is teaming up with Google’s parent company Alphabet to create a new company focused on developing bioelectronic medicines.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
